John Ransom
Stock Analyst at Raymond James
(3.66)
# 744
Out of 4,896 analysts
227
Total ratings
64.65%
Success rate
15.3%
Average return
Main Sectors:
Stocks Rated by John Ransom
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CI The Cigna Group | Maintains: Strong Buy | $360 → $385 | $303.27 | +26.95% | 18 | May 5, 2025 | |
UNH UnitedHealth Group | Reiterates: Strong Buy | $635 → $540 | $304.10 | +77.57% | 13 | Apr 21, 2025 | |
RDNT RadNet | Upgrades: Strong Buy | $85 → $65 | $55.48 | +17.16% | 11 | Mar 5, 2025 | |
HCA HCA Healthcare | Downgrades: Market Perform | n/a | $376.07 | - | 21 | Nov 22, 2024 | |
THC Tenet Healthcare | Downgrades: Outperform | $195 | $175.75 | +10.95% | 17 | Nov 22, 2024 | |
CYH Community Health Systems | Downgrades: Underperform | n/a | $3.60 | - | 8 | Nov 22, 2024 | |
SCI Service Corporation International | Maintains: Outperform | $80 → $85 | $80.77 | +5.24% | 12 | Nov 1, 2024 | |
GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $4.75 | +110.75% | 2 | May 16, 2024 | |
EHC Encompass Health | Reiterates: Strong Buy | $85 → $95 | $118.43 | -19.78% | 15 | Apr 26, 2024 | |
WBA Walgreens Boots Alliance | Maintains: Market Perform | n/a | $11.52 | - | 7 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | n/a | $97.17 | - | 14 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $230.67 | - | 1 | Mar 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $14.38 | +39.08% | 1 | Mar 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $26.72 | +12.28% | 12 | Mar 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $13.37 | -10.25% | 9 | Jan 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $64.78 | +31.21% | 7 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $110.00 | -4.55% | 8 | Aug 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $4.98 | +101.01% | 4 | Aug 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.07 | - | 7 | May 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.89 | - | 11 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.08 | - | 7 | May 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $85 → $100 | $24.36 | +310.51% | 8 | Aug 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $49.64 | - | 2 | Feb 14, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $26.59 | - | 2 | Dec 20, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $142.55 | - | 8 | Nov 7, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $22.04 | - | 2 | Aug 9, 2017 |
The Cigna Group
May 5, 2025
Maintains: Strong Buy
Price Target: $360 → $385
Current: $303.27
Upside: +26.95%
UnitedHealth Group
Apr 21, 2025
Reiterates: Strong Buy
Price Target: $635 → $540
Current: $304.10
Upside: +77.57%
RadNet
Mar 5, 2025
Upgrades: Strong Buy
Price Target: $85 → $65
Current: $55.48
Upside: +17.16%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $376.07
Upside: -
Tenet Healthcare
Nov 22, 2024
Downgrades: Outperform
Price Target: $195
Current: $175.75
Upside: +10.95%
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $3.60
Upside: -
Service Corporation International
Nov 1, 2024
Maintains: Outperform
Price Target: $80 → $85
Current: $80.77
Upside: +5.24%
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $4.75
Upside: +110.75%
Encompass Health
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $118.43
Upside: -19.78%
Walgreens Boots Alliance
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $11.52
Upside: -
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $97.17
Upside: -
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $230.67
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $14.38
Upside: +39.08%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $26.72
Upside: +12.28%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $13.37
Upside: -10.25%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $64.78
Upside: +31.21%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $110.00
Upside: -4.55%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $4.98
Upside: +101.01%
May 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $4.07
Upside: -
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $3.89
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $21.08
Upside: -
Aug 1, 2022
Maintains: Strong Buy
Price Target: $85 → $100
Current: $24.36
Upside: +310.51%
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $49.64
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $26.59
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $142.55
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $22.04
Upside: -